Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 8 | 2022 | 643 | 1.160 |
Why?
|
| Photochemotherapy | 7 | 2019 | 59 | 1.050 |
Why?
|
| Apoptosis | 7 | 2014 | 1641 | 0.810 |
Why?
|
| Photosensitizing Agents | 5 | 2014 | 32 | 0.680 |
Why?
|
| NF-kappa B | 2 | 2014 | 432 | 0.620 |
Why?
|
| Acetylcysteine | 2 | 2014 | 296 | 0.580 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2012 | 629 | 0.570 |
Why?
|
| Lysosomes | 3 | 2012 | 136 | 0.560 |
Why?
|
| Hypoxia | 3 | 2007 | 169 | 0.530 |
Why?
|
| Indoles | 3 | 2012 | 146 | 0.510 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2012 | 756 | 0.500 |
Why?
|
| Deoxycytidine | 1 | 2014 | 83 | 0.470 |
Why?
|
| Iron | 2 | 2012 | 197 | 0.460 |
Why?
|
| Cation Transport Proteins | 1 | 2012 | 11 | 0.430 |
Why?
|
| Head and Neck Neoplasms | 3 | 2019 | 561 | 0.420 |
Why?
|
| Glutathione | 3 | 2014 | 343 | 0.410 |
Why?
|
| Cell Line, Tumor | 7 | 2019 | 1851 | 0.380 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 332 | 0.380 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2009 | 41 | 0.330 |
Why?
|
| Iron Chelating Agents | 2 | 2022 | 31 | 0.310 |
Why?
|
| Signal Transduction | 2 | 2014 | 2689 | 0.300 |
Why?
|
| Cell Nucleus | 2 | 2007 | 305 | 0.300 |
Why?
|
| Calcium | 2 | 2022 | 929 | 0.290 |
Why?
|
| Transcription Factor RelA | 1 | 2007 | 47 | 0.290 |
Why?
|
| Muscle Proteins | 1 | 2005 | 94 | 0.250 |
Why?
|
| Neoplasms | 2 | 2005 | 1667 | 0.230 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 271 | 0.230 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 411 | 0.220 |
Why?
|
| Cytological Techniques | 1 | 2002 | 23 | 0.210 |
Why?
|
| Macrolides | 2 | 2012 | 48 | 0.210 |
Why?
|
| Fluorescent Dyes | 1 | 2022 | 191 | 0.190 |
Why?
|
| Microscopy, Confocal | 4 | 2014 | 337 | 0.190 |
Why?
|
| Transcription Factors | 1 | 2005 | 753 | 0.190 |
Why?
|
| Cell Survival | 4 | 2019 | 901 | 0.180 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 2 | 2014 | 17 | 0.180 |
Why?
|
| Chlorophyll | 1 | 2019 | 6 | 0.170 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2019 | 35 | 0.170 |
Why?
|
| Fibroblasts | 1 | 2004 | 902 | 0.170 |
Why?
|
| Animals | 9 | 2022 | 20881 | 0.170 |
Why?
|
| Mice | 6 | 2022 | 8474 | 0.160 |
Why?
|
| Oxidative Stress | 2 | 2014 | 718 | 0.150 |
Why?
|
| Reactive Oxygen Species | 2 | 2012 | 499 | 0.140 |
Why?
|
| Transcriptional Activation | 2 | 2007 | 226 | 0.130 |
Why?
|
| Isoindoles | 2 | 2012 | 9 | 0.120 |
Why?
|
| Gels | 1 | 2014 | 55 | 0.120 |
Why?
|
| Cysteine | 1 | 2014 | 112 | 0.120 |
Why?
|
| Humans | 11 | 2019 | 68618 | 0.120 |
Why?
|
| Mice, Nude | 1 | 2014 | 294 | 0.110 |
Why?
|
| Drug Delivery Systems | 2 | 2014 | 236 | 0.110 |
Why?
|
| Chelating Agents | 1 | 2012 | 47 | 0.110 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2012 | 3 | 0.100 |
Why?
|
| Nanoparticles | 1 | 2014 | 254 | 0.100 |
Why?
|
| Light | 1 | 2012 | 152 | 0.090 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2010 | 22 | 0.090 |
Why?
|
| Muramidase | 1 | 2010 | 38 | 0.090 |
Why?
|
| Reye Syndrome | 1 | 2009 | 11 | 0.090 |
Why?
|
| Silicon | 1 | 2009 | 20 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 659 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2022 | 2673 | 0.080 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2009 | 84 | 0.080 |
Why?
|
| Models, Biological | 1 | 2012 | 981 | 0.080 |
Why?
|
| Glutaredoxins | 1 | 2007 | 12 | 0.070 |
Why?
|
| Catalysis | 1 | 2007 | 123 | 0.070 |
Why?
|
| Cytoplasm | 1 | 2007 | 155 | 0.070 |
Why?
|
| Oxidoreductases | 1 | 2007 | 117 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 304 | 0.070 |
Why?
|
| Liver Transplantation | 1 | 2009 | 400 | 0.070 |
Why?
|
| Coloring Agents | 2 | 2003 | 66 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2005 | 24 | 0.070 |
Why?
|
| Cell Hypoxia | 1 | 2005 | 92 | 0.060 |
Why?
|
| Transfection | 1 | 2007 | 782 | 0.060 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 55 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 71 | 0.060 |
Why?
|
| Oxygen | 1 | 2007 | 386 | 0.060 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2005 | 100 | 0.060 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2004 | 28 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2005 | 289 | 0.060 |
Why?
|
| I-kappa B Proteins | 1 | 2004 | 47 | 0.060 |
Why?
|
| Cytochromes c | 1 | 2004 | 75 | 0.060 |
Why?
|
| DNA | 1 | 2007 | 597 | 0.060 |
Why?
|
| Time Factors | 1 | 2012 | 4655 | 0.060 |
Why?
|
| Acridine Orange | 1 | 2003 | 3 | 0.060 |
Why?
|
| Cardiolipins | 1 | 2003 | 12 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2005 | 231 | 0.060 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2003 | 45 | 0.060 |
Why?
|
| Annexin A5 | 1 | 2002 | 16 | 0.050 |
Why?
|
| Resins, Synthetic | 1 | 2002 | 7 | 0.050 |
Why?
|
| Oxyquinoline | 1 | 2022 | 6 | 0.050 |
Why?
|
| Rhodamine 123 | 1 | 2022 | 13 | 0.050 |
Why?
|
| Thapsigargin | 1 | 2022 | 18 | 0.050 |
Why?
|
| DNA Fragmentation | 1 | 2002 | 85 | 0.050 |
Why?
|
| Cations, Divalent | 1 | 2022 | 27 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2002 | 160 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2002 | 144 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 351 | 0.050 |
Why?
|
| Fluorescence | 1 | 2022 | 104 | 0.050 |
Why?
|
| Caspases | 1 | 2002 | 194 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2002 | 233 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2022 | 113 | 0.050 |
Why?
|
| Proteins | 1 | 2004 | 474 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 1174 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 1070 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2019 | 237 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 170 | 0.040 |
Why?
|
| Ligands | 1 | 2019 | 317 | 0.040 |
Why?
|
| ErbB Receptors | 1 | 2019 | 239 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2003 | 778 | 0.040 |
Why?
|
| Male | 3 | 2014 | 37321 | 0.040 |
Why?
|
| Rats | 1 | 2005 | 5300 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1174 | 0.030 |
Why?
|
| Receptors, sigma | 1 | 2014 | 6 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2014 | 282 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2014 | 90 | 0.030 |
Why?
|
| Temperature | 1 | 2014 | 341 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 618 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2010 | 61 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2010 | 397 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 954 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2009 | 346 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1745 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2003 | 92 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 112 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 852 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 631 | 0.010 |
Why?
|